P/E ratio for InterCure (INCR)
P/E ratio as of July 2025 (TTM): 9.67
According to InterCure's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 9.66632. At the end of 2023 the company had a P/E ratio of -3.41.
P/E ratio history for InterCure from 2019 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2023 | -3.41 | -129.05% |
| 2022 | 11.8 | -93.01% |
| 2021 | 168 | -5950.91% |
| 2020 | -2.87 | -81.12% |
| 2019 | -15.2 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.